Accolade Inc (NAS:ACCD)
$ 7.08 -0.08 (-1.12%) Market Cap: 554.77 Mil Enterprise Value: 565.65 Mil PE Ratio: 0 PB Ratio: 1.25 GF Score: 75/100

Accolade Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 14, 2021 / 07:50PM GMT
Release Date Price: $47.76 (+0.19%)
Rajeev Singh
Accolade, Inc. - CEO & Executive Director

Hello, everyone, and thank you for joining us for the Accolade investor presentation. We're pleased to join you. My name is Rajeev Singh. I'm the CEO of Accolade. Joining me as well is Steve Barnes, our Chief Financial Officer.

We'll be referring to the presentation that, hopefully, you have in front of you. We'll be -- we'll attempt to be conscientious about moving you from one slide to the next.

So to begin, we'll ask you to advance to Slide 2, our safe harbor statement. Given your -- given most people's understanding of the safe harbor statement, I'll avoid reading it to you, but just make you aware of the fact that we'll be making -- we'll be speaking qualitatively to our business. And the risk factors are pointed out on the slide.

Moving to Slide 3. We'll start by telling you a little bit about Accolade and what we do, and what foundationally are the elements of our service. Perhaps, again, moving to Slide 4. It escapes no one at the JPMorgan Healthcare Conference that the health care system is broken. We

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot